Multidetector Computed Tomography in Patients Who Underwent Transcatheter Mitral Edge-to-Edge Repair.
Humans
Multidetector Computed Tomography
Mitral Valve
/ diagnostic imaging
Mitral Valve Insufficiency
/ surgery
Heart Valve Prosthesis Implantation
/ methods
Transcatheter Aortic Valve Replacement
Echocardiography, Three-Dimensional
/ methods
Echocardiography, Transesophageal
/ methods
Calcinosis
Treatment Outcome
MitraClip
computed tomography
transcatheter edge-to-edge repair
transesophageal echocardiography
Journal
The American journal of cardiology
ISSN: 1879-1913
Titre abrégé: Am J Cardiol
Pays: United States
ID NLM: 0207277
Informations de publication
Date de publication:
01 12 2023
01 12 2023
Historique:
received:
13
04
2023
revised:
03
09
2023
accepted:
06
09
2023
medline:
13
11
2023
pubmed:
13
10
2023
entrez:
12
10
2023
Statut:
ppublish
Résumé
Multidetector computed tomography (MDCT) can provide valuable information for mitral assessment, but its role in transcatheter mitral edge-to-edge repair (TEER) planning has been poorly elucidated. We aimed to compare MDCT with 3-dimensional transesophageal echocardiography (3D-TEE) for TEER preprocedural evaluation. We analyzed the preprocedural MDCT and 3D-TEE of 108 consecutive patients with mitral regurgitation (MR) who underwent MitraClip implantation. The levels of agreement for the etiology and mechanism of MR, mitral calcification, mitral annulus, and mitral valve orifice area (MVOA) measurements were compared between MDCT and 3D-TEE data. Receiver-operating-characteristic curves were generated for mitral annulus area and MVOA using a low mean transmitral pressure gradient at discharge (<5 mm Hg) as the state variable, and the primary outcome of all-cause mortality or rehospitalization for heart failure at 1 year was compared between MDCT's and 3D-TEE's MVOA <4-cm
Identifiants
pubmed: 37827014
pii: S0002-9149(23)00995-5
doi: 10.1016/j.amjcard.2023.09.027
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
101-110Informations de copyright
Copyright © 2023 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest Dr. Makkar has received grant support from Edwards Lifesciences Corporation, is a consultant for Abbott Vascular, Cordis, and Medtronic, and holds equity in Entourage Medical. Dr. Chakravarty is a consultant, proctor, and speaker for Edwards Lifesciences and Medtronic, a consultant for Abbott Lifesciences, and a consultant and speaker for Boston Scientific. The remaining authors have no competing interests to declare.